As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs Vivodyne could capitalize on the desire for new approaches to preclinical research

https://www.statnews.com/2025/05/29/animal-testing-alternatives-biotech-vivodyne-raises-40-million-for-organoid-research/